Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Cancers|July 12, 2025
High HER2 Intratumoral Heterogeneity Is Resistant to Anti-HER2 Neoadjuvant Chemotherapy in Early Stage and Locally Advanced HER2-Positive Breast CancerTakaaki Hatano, Tomonori Tanei, Shigeto Seno, et al.
Frontiers in Oncology|March 25, 2026
Analysis of <i>PIK3CA</i> mutations in the lysate of sentinel lymph nodes in patients with early breast cancerSung Ae Park, Nanae Masunaga, Takanori Kin, et al.
International Cancer Conference Journal|January 27, 2026
A rare case of mastitis involving granulomatosis with polyangiitis after immune checkpoint inhibitor therapyChieko Mishima, Akane Watanabe, Yuichi Motoyama, et al.
Cureus|July 21, 2025
Integrative Radiogenomics Using MRI Radiomics and Microarray Gene Expression Analysis to Predict Pathological Complete Response in Patients with Breast Cancer Undergoing Neoadjuvant ChemotherapySoya Oda, Yukiko Tokuda, Yuki Suzuki, et al.
Annals of Surgical Oncology|July 7, 2018
Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node MetastasisKenzo Shimazu, Nobuaki Sato, Akiko Ogiya, et al.
Oncology Reports|August 16, 2021
Comparison of the multigene panel test and OncoScan™ for the determination of <i>HER2</i> amplification in breast cancerKaori Akazawa, Naofumi Kagara, Yoshiaki Sota, et al.
Translational Oncology|December 19, 2020
Determining homologous recombination deficiency scores with whole exome sequencing and their association with responses to neoadjuvant chemotherapy in breast cancerSeung Jin Kim, Yoshiaki Sota, Yasuto Naoi, et al.
Breast Cancer (Tokyo, Japan)|October 28, 2025
Targeting focal adhesion kinase inhibits cell migration and non-angiogenic vascularization in malignant breast cancerMisato Masuyama, Masafumi Shimoda, Ikumi Seto, et al.
Cancers|March 13, 2024
High HER2 Intratumoral Heterogeneity Is a Predictive Factor for Poor Prognosis in Early-Stage and Locally Advanced HER2-Positive Breast CancerTomonori Tanei, Shigeto Seno, Yoshiaki Sota, et al.
Cancer Reports (Hoboken, N.J.)|April 24, 2026
Altered Estrogen Receptor Signaling Pathway in BRCA2-Deficient Estrogen Receptor-Positive/HER2-Negative Breast CancerKaori Kawasaki, Misato Masuyama, Masafumi Shimoda, et al.
Pageof 4